MOBILE   |  REGISTER   |   LOGIN   |   HELP
HOME  |  ABOUT US  |  BLOGGERS  |  BLOGS  |  MESSAGES  |  VIDEO  |  QUIZZES  |  LIBRARY  |  WEBINARS
A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies
Blog Roll
Lori Smith

Today Is Kick Butts Day Are You Ready?

NO RATINGS
View Comments: Newest First | Oldest First | Threaded View
More Blogs from...
Lori Smith
Nurse practitioner Lori Smith verbalizes concern over the potential repeal of the ACA and what it could mean in terms of cancer screenings.
Nurse practitioner Lori Smith explains the actual mortality rates when it comes to cervical cancer.
Nurse practitioner Lori Smith shares information on a new drug recently approved for ovarian cancer.
Nurse practitioner Lori Smith shares the most recent regimen approval for recurrent ovarian cancer.
Nurse practitioner Lori Smith shares a new study taking place using gut flora in women with ovarian cancer.
Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT
Archived

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Readerboards
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
nixsolutiql on Enhance your Business through Excellent Website Promotion
nixsolutiql on Enhance your Business through Excellent Website Promotion
nixsolutiql on Cancer Patient Fall Prevention
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed
TheONC.org